Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation- inducing agent
Year: 1992
Type: article
Study design: Clinical Trial
Source: Blood
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Award: Cancer Center Support Grant
OpenAlex ID: W266859766
